UnitedHealth Group Incorporated (NYSE:UNH) Holdings Lowered by Mader & Shannon Wealth Management Inc.

Mader & Shannon Wealth Management Inc. decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,487 shares of the healthcare conglomerate’s stock after selling 751 shares during the quarter. UnitedHealth Group makes up 4.6% of Mader & Shannon Wealth Management Inc.’s holdings, making the stock its 9th largest position. Mader & Shannon Wealth Management Inc.’s holdings in UnitedHealth Group were worth $7,886,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group during the third quarter valued at approximately $27,000. Global Wealth Strategies & Associates increased its holdings in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Macroview Investment Management LLC increased its holdings in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 47 shares during the last quarter. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $32,000. Finally, Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.1 %

Shares of NYSE UNH opened at $590.87 on Friday. The stock has a market cap of $543.77 billion, a P/E ratio of 38.49, a PEG ratio of 1.75 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The business’s fifty day simple moving average is $582.63 and its 200-day simple moving average is $552.95.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the firm earned $6.56 earnings per share. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Wall Street Analyst Weigh In

UNH has been the subject of several recent research reports. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Bank of America lowered their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Morgan Stanley lowered their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Finally, Stephens lowered their price objective on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.